Beyond Celiac, NMQF study to examine and address health inequities in the diagnosis and treatment of celiac disease presented at largest global gathering of gastroenterologists
Early results of ACeD study (Assessment of KAN-101 in Celiac Disease), show that KAN-101 induced T-cell tolerance of gliadin, the harmful component of gluten, in study participants after they were given a gluten challenge.
You aren't alone if you feel like gluten exposure makes you feel sicker ever since your celiac disease diagnosis.
At the recent Beyond Celiac Research Summit, scientists presented details of celiac disease studies exploring immune reactions, the gut-brain connection, the effect of screening for diagnosis among children and the interpretation of biopsy results. Read what they had to say in two research news posts.
Young adults who had been diagnosed with celiac disease as part of a broad screening program when they were kids have often abandoned the gluten-free diet, according to an 20-year follow-up Italian study.
Cystic fibrosis patients banded together and changed the future for those living with the disease. Can increased patient participation produce similar results for celiac disease?
An Increased risk of cancer in celiac disease is small and limited to diagnosis after 40, according to a new study from Sweden
In a five-year follow-up, about 30 percent of children with potential celiac disease went on to be diagnosed with celiac disease, according to a recent Swedish study.
Studies have shown that people with celiac disease on the gluten-free diet continue to have symptoms, elevated antibodies to gluten detected in blood tests, and damage to the nutrient-absorbing lining of the intestine.
After years of working to accelerate celiac disease science, Beyond Celiac was thrilled to see a burst of new and exciting research published in 2021
People with celiac disease get more headaches, including migraines, and women get more migraines than men, according to a new study.
The reliability of urine tests to determine how much gluten might be getting into the gluten-free diet is questioned in a new study. Meanwhile other scientists defend the accuracy of the tests based on the results of previous research.
Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials
If you are Black or have public insurance and also have symptoms associated with celiac disease or inflammatory bowel disease, your chance of getting proper follow-up for diagnosis is greatly reduced, a recent study found.
Children who had no symptoms but were diagnosed with celiac disease as part of a mass pediatric screening program reported a better quality of life overall after a year on the gluten-free diet, preliminary results of a study funded by Beyond Celiac show.
An international group of researchers are investigating a monoclonal antibody that has the potential to treat celiac disease by stopping the activation of cells that identify gluten as an invader.
Italian researchers hypothesize that COVID-19 could have implications for those who are genetically at risk for celiac disease
The mouth and the intestine share characteristics that might make a saliva test for celiac disease the first step in diagnosis, a new study from Spain suggests.
Two European studies paint a discouraging picture of how well celiac disease is understood in the medical community. Some of what they conclude is likely to be applicable to the United States, too.
Intestinal changes that occur before the development of celiac disease in at-risk children have been identified in a new study. The results are promising for potentially identifying ways to intervene before celiac disease develops, according to study authors.
PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.
Recently, the European Academy of Dermatology and Venereology compiled guidelines to support dermatologists in diagnosis and treatment of DH and improve the quality of management for patients.
A new drug being investigated to treat celiac disease reduced intestinal damage in patients undergoing a gluten challenge, early results reported in a new study found.
The breast milk of mothers with celiac disease on a gluten-free diet is not functionally different from the breast milk of mothers who don't have celiac disease, a new study finds.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
